Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
Author:
Funder
Swedish Children Cancer Foundation
Publisher
Elsevier BV
Subject
Transplantation,Hematology
Reference44 articles.
1. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009;Ljungman;Bone Marrow Transplant,2010
2. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection;Storb;N Engl J Med,1977
3. No difference in graft-versus-host disease, relapse and survival comparing peripheral stem cells with bone marrow using unrelated donors;Remberger;Blood,2001
4. Impact of CD34 subsets on engraftment kinetics in allogeneic peripheral blood stem cell transplantation;Kamel;Bone Marrow Transplant,2005
5. Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia;Niederwieser;Br J Haematol,1988
Cited by 106 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of graft CD34+ cell counts on hematological recovery in patients receiving post-transplant cyclophosphamide prophylaxis;Bone Marrow Transplantation;2024-07-27
2. Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide;Transplantation and Cellular Therapy;2024-06
3. High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality;Transfusion;2024-05
4. Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche;Annals of Hematology;2024-04-30
5. Effects of CD34+ cell dose on engraftment and long‐term outcomes after allogeneic bone marrow transplantation;Clinical Transplantation;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3